PRF Technologies Ltd. provided a business update for the year ended December 31, 2025, highlighting strategic progress in its healthcare and AI-driven solar platforms, including the acquisition of DeepSolar and a majority investment in LayerBio. The company reported a net loss of approximately $4.8 million for the year, compared to a net loss of approximately $14.6 million in the prior year.
Key takeaways
Completed strategic acquisition of DeepSolar, expanding into AI-driven solar analytics.
Completed majority investment in LayerBio, adding OcuRing™-K, a patented sustained-release ocular therapy platform.
Reported net loss of approximately $4.8 million for the year ended December 31, 2025, compared to net loss of approximately $14.6 million for the prior year.
Ended 2025 with approximately $4.1 million in cash, cash equivalents, short-term deposits and restricted cash, and positive working capital of approximately $1.9 million.
Research and development expenses were approximately $1.1 million for 2025, compared to approximately $11.7 million for 2024, primarily due to extensive clinical trial costs in 2024.
DeepSolar expanded commercial footprint through SaaS agreement with Shikun & Binui Energy for a 71 MW solar project in Romania and first commercial due diligence engagement with EDF Power Solutions Israel.